Jazz Pharmaceuticals (JAZZ)
Healthcare · Biotechnology
1 member of Congress has disclosed 3 trades in Jazz Pharmaceuticals (JAZZ) since 2023: 1 buy and 2 sales. The most recent was disclosed on Aug 13, 2023.
- Trades disclosed
- 3
- Members trading
- 1
- Buys / sells
- 1 / 2
- Reported value
- $31K–$115K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at JAZZ
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded JAZZ
- Rep. Daniel S. Goldman (D-NY-10)1 buy · 2 sales12Aug 13, 2023
All trades
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Jazz Pharmaceuticals JAZZ
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- Apr 17, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Bought Jazz Pharmaceuticals JAZZ
$15K–$50K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Jazz Pharmaceuticals JAZZ
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.